Search results
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 18 hours agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
Anthony Fauci faces grilling by Republicans over COVID-19 response, origins
Good Morning America via Yahoo News· 19 minutes agoFauci previously proclaimed that he has "nothing to hide" and is coming before the Select...
The COVID-19 Vaccines Shouldn't Have Been Free
Reason.com via Yahoo News· 4 days agoTheir basic takeaway is that the vaccines were a "scientific success" tarnished by flawed federal vaccine policy. The two argue the tremendous benefits...
Watch Live: Dr. Anthony Fauci testifies on COVID pandemic response for Republican-led House panel
CBS News· 2 hours agoDr. Anthony Fauci is testifying on Monday before a Republican-led House panel investigating the...
Fauci testifies publicly before House panel on COVID origins, controversies
The Columbian· 44 minutes agoDr. Anthony Fauci, the top U.S. infectious disease expert until leaving the government in 2022,...
Rep Raskin says House Republicans are treating Fauci ‘like a felon’ over GOP inquiry: Live updates
The Independent via Yahoo News· 44 minutes agoDr Fauci, the former head of the NIAID, is facing questions from the GOP-led subcommittee...
Live Updates: Dr. Anthony Fauci testifies on origins of COVID-19
Newsweek· 2 hours agoDr. Anthony Fauci is testifying before the House Oversight and Accountability Committee on the...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 3 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
What to make of the new COVID variants, FLiRT
MPR News· 29 minutes agoDr. Ashish Jha, the dean of the Brown University School of Public Health and former White House COVID-19 response coordinator, returned to All Things...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via Yahoo News· 4 hours agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...